Form D · Other
Origin Biomed Inc
Halifax, A5 · CIK 0001407422
Offering snapshot reported May 27, 2009 · SEC filing
- Reported sold
- $3.27M Offering amount: $3.99M
- Investors reported
- Not reported Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- Not reported As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 27, 2009 | Initial | $3,266,634 | No comparison | Not reported | SEC filing |
| Feb 2, 2009 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jul 19, 2007 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- Not reported
- Finders' fees
- Not reported
- Form D file number
- 021-106379
Source: Form D, filed May 27, 2009. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gordon Buchan | Director |
| Robert Cervelli | Director |
| Aki Georgacacos | Director |
| Peter Mac Neil | Director |
| Murray Mc Laughlin | Director |
| Ron Mitton | Director |
| Barry Tuner | Director |
Issuer details
Industry: Other (See others in industry)
Address:
5162 Duke Str Suite 500
Halifax, A5, B3J 1N7
Halifax, A5, B3J 1N7